Leveraging speech and artificial intelligence to screen for early Alzheimer's disease and amyloid beta positivity
Open accessThe DOI matches its Crossref record; 52 of the 55 references it cites were found in a registry or an index.
Abstract
Early detection of Alzheimer’s disease is required to identify patients suitable for disease-modifying medications and to improve access to non-pharmacological preventative interventions. Prior research shows detectable changes in speech in Alzheimer’s dementia and its clinical precursors. The current study assesses whether a fully automated speech-based artificial intelligence system can detect cognitive impairment and amyloid beta positivity, which characterize early stages of Alzheimer’s disease. Two hundred participants (age 54–85, mean 70.6; 114 female, 86 male) from sister studies in the UK (NCT04828122) and the USA (NCT04928976), completed the same assessments and were combined in the current analyses. Participants were recruited from prior clinical trials where amyloid beta status (97 amyloid positive, 103 amyloid negative, as established via PET or CSF test) and clinical diagnostic status was known (94 cognitively unimpaired, 106 with mild cognitive impairment or mild Alzheimer’s disease). The automatic story recall task was administered during supervised in-person or telemedicine assessments, where participants were asked to recall stories immediately and after a brief delay. An artificial intelligence text-pair evaluation model produced vector-based outputs from the original story text and recorded and transcribed participant recalls, quantifying differences between them. Vector-based representations were fed into logistic regression models, trained with tournament leave-pair-out cross-validation analysis to predict amyloid beta status (primary endpoint), mild cognitive impairment and amyloid beta status in diagnostic subgroups (secondary endpoints). Predictions were assessed by the area under the receiver operating characteristic curve for the test result in comparison with reference standards (diagnostic and amyloid status). Simulation analysis evaluated two potential benefits of speech-based screening: (i) mild cognitive impairment screening in primary care compared with the Mini-Mental State Exam, and (ii) pre-screening prior to PET scanning when identifying an amyloid positive sample. Speech-based screening predicted amyloid beta positivity (area under the curve = 0.77) and mild cognitive impairment or mild Alzheimer’s disease (area under the curve = 0.83) in the full sample, and predicted amyloid beta in subsamples (mild cognitive impairment or mild Alzheimer’s disease: area under the curve = 0.82; cognitively unimpaired: area under the curve = 0.71). Simulation analyses indicated that in primary care, speech-based screening could modestly improve detection of mild cognitive impairment (+8.5%), while reducing false positives (−59.1%). Furthermore, speech-based amyloid pre-screening was estimated to reduce the number of PET scans required by 35.3% and 35.5% in individuals with mild cognitive impairment and cognitively unimpaired individuals, respectively. Speech-based assessment offers accessible and scalable screening for mild cognitive impairment and amyloid beta positivity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“while in the semantic variant PPA, spontaneous speech is fluent but marked by semantic errors, reduced specificity, and loss of content due to degradation of conceptual knowledge.90”
From Review of Artificial Intelligence for Clinical Use in Alzheimer's Disease and Related Dementias (2026) · cites this paper as [90]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Dementia prevention, intervention, and care: 2020 report of the Lancet Commission
Livingston, G., Huntley, J., Sommerlad, A., Ames, D., Ballard, C., Banerjee, S., Brayne, C., Burns, A., Cohen-Mansfield, J., Cooper, C., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30367-6 · Cited by 10,430
RetractedFolstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282 · cited 7×
“31 The composite includes summary scores from five measures: (i) the MMSE, 29 a global cognitive screening test; (ii) the Logical Memory Delayed Recall, 8,32 a delayed story recall test; (iii) Digit-Symbol Coding, 33 a symbol sub-stitution test; (iv) the sum of free and total recall from the Free…”
InfluentialHirono, N., Mori, E., Ikejiri, Y., Imamura, T., Shimomura, T., Hashimoto, M., Yamashita, H., & Ikeda, M. (1997) · Brain and nerve · Cited by 21,038
Kok, J. S., Berg, I. J., & Scherder, E. J. A. (2013) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000353441 · Cited by 20,589
Older Adults' Reasons for Using Technology while Aging in Place
Peek, S. T. M., Luijkx, K. G., Rijnaard, M. D., Nieboer, M. E., van der Voort, C. S., Aarts, S., van Hoof, J., Vrijhoef, H. J. M., & Wouters, E. J. M. (2016) · Gerontology · doi:10.1159/000430949 · Cited by 19,690
Sensitivity and False Alarm Rate of a Fall Sensor in Long-Term Fall Detection in the Elderly
Kangas, M., Korpelainen, R., Vikman, I., Nyberg, L., & Jämsä, T. (2015) · Gerontology · doi:10.1159/000362720 · Cited by 18,909
McKhann, G. M., Knopman, D. S., Chertkow, H., Hyman, B. T., Jack, C. R., Kawas, C. H., Klunk, W. E., Koroshetz, W. J., Manly, J. J., Mayeux, R., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.005 · Cited by 18,657
Albert, M. S., DeKosky, S. T., Dickson, D., Dubois, B., Feldman, H. H., Fox, N. C., Gamst, A., Holtzman, D. M., Jagust, W. J., Petersen, R. C., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.008 · Cited by 10,152
The Clinical Dementia Rating (CDR): Current version and scoring rules
Morris, J. C. (1993) · Neurology · doi:10.1212/wnl.43.11.2412-a · Cited by 9,882 · cited 1×
“…English as a first language; availability of a study partner to support completing the Clinical Dementia Rating scale (CDR) semi-structured interview 30 ; ability to use and access a smartphone (Android 7 or above or iOS 11 or above), for a fully remote component of the study reported elsewhere.”
Longformer: The Long-Document Transformer
Beltagy, I., Peters, M. E., & Cohan, A. (2020) · arXiv · doi:10.48550/arxiv.2004.05150 · Cited by 2,281
Research works printed but not linked: 2
- Wechsler, 2008, WAIS-R Manual: Wechsler Adult Intelligence Scale-Revised
- Liu, 2019, RoBERTa: A robustly optimised BERT pretraining approach, arXiv
Cited by
Veneziani, I., Marra, A., Formica, C., Grimaldi, A., Marino, S., Quartarone, A., & Maresca, G. (2024) · Journal of Personalized Medicine · doi:10.3390/jpm14010113 · Cited by 54
“Notably, an automatically administered and analyzed screening speech-based test was able to predict Amyloid-β (A β ) positivity and MCI [43].”
Perceptions of Artificial Intelligence and ChatGPT by Speech-Language Pathologists and Students
Austin, J., Benas, K., Caicedo, S., Imiolek, E., Piekutowski, A., & Ghanim, I. (2025) · American Journal of Speech-Language Pathology · doi:10.1044/2024_ajslp-24-00218 · Cited by 31
Screening for early Alzheimer’s disease: enhancing diagnosis with linguistic features and biomarkers
Chou, C., Chang, C.-T., Chang, Y., Lee, C., Chuang, Y., Chiu, Y., Liang, W.-L., Fan, Y.-M., & Liu, Y. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1451326 · Cited by 34
Zarei, O., moghaddam, M. T., & Vastegani, S. M. (2025) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2025.111667 · Cited by 22
Detection of Alzheimer’s Disease Using Logistic Regression and Clock Drawing Errors
Lazarova, S., Григорова, Д., Petrova‐Antonova, D., & Initiative, A. D. N. (2023) · Brain Sciences · doi:10.3390/brainsci13081139 · Cited by 22
“For instance, screening based on speech patterns [26,27] and mobile applications [28,29] leverages digital versions of widely used cognitive tests.”
BackgroundMiller, M. J., Diaz, A., Conti, C., Albala, B., Flenniken, D., Fockler, J., Kwang, W., Sacrey, D. T., Ashford, M. T., Skirrow, C., et al. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.14234 · Cited by 21
“Participants are asked to provide information about their location, including the option to provide a complete address.”
Self-citationHabbal, S., Mian, M., Imam, M., Tahiri, J., Amor, A., & Reddy, P. H. (2025) · Brain Organoid and Systems Neuroscience Journal · doi:10.1016/j.bosn.2025.05.001 · Cited by 19
Bonvino, A., Cornacchia, E., Scaramuzzi, G. F., Gasparre, D., Manippa, V., Rivolta, D., & Taurisano, P. (2025) · Neuropsychology Review · doi:10.1007/s11065-025-09680-8 · Cited by 19
Skirrow, C., Meepegama, U., Weston, J., Miller, M. J., Nosheny, R. L., Albala, B., Weiner, M. W., Fristed, E., & Initiative, A. D. N. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.14206 · Cited by 17
Self-citationWang, J., Zhi, N., Xu, G., Geng, J., Xiao, J.-W., Li, H., Li, J., Xie, X., Song, Y., Cao, W., et al. (2025) · Alzheimer s Research & Therapy · doi:10.1186/s13195-025-01877-6 · Cited by 16
“Further, diagnostic models that rely solely on one speech modality indicator often lack accuracy and specificity [10, 11].”
Khastehband, S., Dabbaghi, K. G., Khosravirad, Z., Jamalnia, S., GhorbaniNia, R., Mahmoudikohani, F., & Zakeri, H. (2023) · Galen Medical Journal · doi:10.31661/gmj.v12i.3061 · Cited by 11
Review of Artificial Intelligence for Clinical Use in Alzheimer's Disease and Related Dementias
Breithaupt, A. G., Tang, A., Paolillo, E. W., Bibars, M., Johnson, E. C. B., Saloner, R., Possin, K. L., Windon, C. C., Hill-Jarrett, T. G., Giorgio, J., et al. (2026) · Seminars in Neurology · doi:10.1055/a-2744-9871 · Cited by 6
Li, Q., Koehler, S., Koenig, A., Dyrba, M., Mallik, E., Linz, N., Priller, J., Spruth, E., Altenstein, S., Wiltfang, J., et al. (2025) · Journal of Alzheimer’s Disease · doi:10.1177/13872877251359967 · Cited by 6
“23 However, limited work has investigated how digital speech features correlate with AD staging markers like brain atrophy or with longitudinal cognitive changes.”
Sajjadi, S. A., Khan, Z., El‐Khoury, A., Bubbico, G., Akhlaghipour, G., Corrada, M. M., Kawas, C. H., & Paganini‐Hill, A. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70450 · Cited by 5
“36,37 The novelty of our study, however, is that we used writing samples that were obtained onaverage 8yearsbefore the development ofcognitive impairment and 12 years before death and showed significant differences in multiple measures between those who developed cognitive impairment and those who…”
König, A., Tröger, J., Mallick, E., Linz, N., Ritchie, C. W., Gregory, S., Hunter, M. B., Johnson, K., Sánchez‐Benavides, G., Grau‐Rivera, O., et al. (2026) · Alzheimer s & Dementia · doi:10.1002/alz.71462 · Cited by 3
Tavakoli, M., Dadgostar, M., Green, J. R., Salat, D. H., Arnold, S. E., Connaghan, K. P., Richburg, B. D., Barnett, N. V., Tkeshelashvili, M., & Eshghi, M. (2026) · JMIR Formative Research · doi:10.2196/89830 · Cited by 2
Alzheimer’s Disease Knowledge Graph Based on Ontology and Neo4j Graph Database
Spasov, I., Lazarova, S., & Petrova‐Antonova, D. (2024) · Lecture notes in networks and systems · doi:10.1007/978-981-99-6544-1_6 · Cited by 2
Differential risk of Alzheimer's disease in MCI subjects with elevated Abeta
Zhou, B., & Fukushima, M. (2024) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2024.123319 · Cited by 4
“An automated speech-based artificial intelligence system predicted amyloid beta positivity (area under the curve = 0.77) in the full sample [21,22].”
InfluentialSpeech biomarkers predict amyloid status in cognitively unimpaired adults
Gabirondo, P., García-Martínez, M., Pozueta‐Cantudo, A., Maran, P. L., Dias, P., Rojo, T., Jiménez-Raboso, J., Lage, C., Martínez‐Dubarbie, F., López‐García, S., et al. (2025) · Intelligence-Based Medicine · doi:10.1016/j.ibmed.2025.100306 · Cited by 2
Saunders, S., Haider, F., Lanzi, A. M., MacWhinney, B., Fromm, D., Chou, C., Liu, Y., Chang, Y., Gregory, S., Ritchie, C. W., et al. (2026) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.70341 · Cited by 1
“15 Finally, speech-based assessments that predict amylo β status 6,16,17 would allow non-invasive screening of AD pathology and eligibility assessmentforanti-amyloidantibodytreatments.”
Jinming, X., Kathiresan, T., Siddiqui, A., & Vogel, A. P. (2026) · Future Neurology · doi:10.1080/14796708.2026.2692075 · Cited by 1
Il contributo dell'intelligenza artificiale nella diagnosi dei disturbi neurodegenerativi
Nappo, R., & Simeoli, R. (2024) · RIVISTA SPERIMENTALE DI FRENIATRIA · doi:10.3280/rsf2024-003008 · Cited by 1
Tungumál og heilabilun: Nýting íslenskra máltæknitóla í greiningu klínískra málsýna
Erlendsdóttir, A. L. (2025) · Skemman
Chen, M., & Han, Y. (2026) · The Journal of Prevention of Alzheimer s Disease · doi:10.1016/j.tjpad.2026.100488 · Cited by 1
“Empirical studies using AI-based speech analysis have shown the ability to predict progression to AD years in advance [4], offering substantial promise for more targeted patient selection.”
Li, Q., Alexopoulou, Z.-S., Dyrba, M., Mallick, E., Tröger, J., Spruth, E. J., Altenstein, S., Bartels, C., Glanz, W., Incesoy, E. I., et al. (2026) · Alzheimer s Research & Therapy · doi:10.1186/s13195-026-01993-x
“These features have also been related to traditional neuropsychological scores and established AD biomarkers, including amyloid beta (Aβ) and phosphorylated tau levels [14, 15].”
The myth of digital biomarkers in Alzheimer's disease: how to make them a reality
Au, R., Gifford, K. A., Paschalidis, I. C., Wighton, P., Levin, M., Imam, F. B., Bose, N., & Pratap, A. (2026) · Current Opinion in Psychiatry · doi:10.1097/yco.0000000000001089
Toward precision neuroscience in Alzheimer’s disease: the role of multimodal AI
Martínez‐Molina, N., Orte, S., Migliorelli, C., & Ribas, V. (2026) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2026.1903637
A neurocognitive speech taxonomy for voice biomarkers of Alzheimer’s diseasePreprint
Henley, B., Yang, Z., Sober, J. D., Calhoun, V., Goldstein, F. C., & Hajjar, I. M. (2026) · medRxiv · doi:10.64898/2026.09.23.26363671
Ashish, R. M., & Turner, J. A. (2026) · JMIR Neurotechnology · doi:10.2196/108372
Klímová, B. (2026) · Clinical Interventions in Aging · doi:10.2147/cia.s633855
“31 Garcia-Gutiérrez and colleagues trained machine-learning classifiers on spontaneous speech recordings to grade cognitive impairment across the entire AD spectrum, achieving high classification performance.”
Santiago, L. R., Kabir, I. M., Hasbahr, V. S., Timoteo, L. M. M., Tamayo, E. A. P., Hadad, H. R. G., Muniz, L. V., Pereira, L. X., Halim, P., Nurkolis, F., et al. (2026) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2026.112041
Metadata
- Authors
- Fristed, E., Skirrow, C., Meszaros, M., Lenain, R., Meepegama, U., Papp, K. V., Ropacki, M., & Weston, J.
- Affiliations
- Novoic Ltd , London, N1 7EU , UK
- Brigham and Women's Hospital (US)
- Strategic Global Research & Development , Temecula, California, 94019 , USA
- Corresponding author
- Skirrow, Caroline
- ORCID
- Venue
- Brain Communications
- Publisher
- Oxford University Press (OUP)
- Published
- 2022-09-01
- Volume
- 4
- Issue
- 5
- Pages
- fcac231-fcac231
- ISSN
- 2632-1297 (ISSN-L)
- PMC
- PMC9639797
- OpenAlex
- W4306403642
- Cited by
- 29
- References
- 55
- Citations by year
- 2026: 9 · 2025: 10 · 2024: 8 · 2023: 2
- FWCI
- 3.26
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Brain Communications (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Bristol Research (University of Bristol) (submittedVersion, cc-by)
- Explore Bristol Research (submittedVersion, cc-by)
- Funders
- Novoic
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Health Professions › Health Information Management › Artificial Intelligence in Healthcare
- Keywords
- Alzheimer's disease, automated speech analysis, artificial intelligence, mild cognitive impairment, early detection, story recall, primary care screening, telemedicine, cognitive screening, false positives
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.